Product Information
ARANESP 25 MCG/ML VIAL is a brand product labeled by Amgen Inc., priced at $185.3625 per ML under NDC 55513000204. Its NADAC has been published 52 times since Apr 23, 2025.
Strength
25 ug/mL
Manufacturer
Amgen Inc.NDC
55513000204
Classification
Brand
Dosage Form
SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
4/23/2025
Active Ingredients
DARBEPOETIN ALFAApproval Type
Biologic (BLA)
FDA Application
BLA103951On Market Since
9/11/2006
Pharmacological Classes
Price Statistics
The NADAC for ARANESP 25 MCG/ML VIAL has been published 52 times since Apr 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $185.3625 per ML |
|---|---|
| All-time high | $185.3625 (Apr 15, 2026) |
| All-time low | $185.3625 (Apr 23, 2025) |
| 52-week high | $185.3625 |
| 52-week low | $185.3625 |
| Median price | $185.3625 |
| Average price | $185.3625 |
| Largest weekly change | 0.0% (Apr 30, 2025) |
| Weeks tracked | 52 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ARANESP 25 MCG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ARANESP 25 MCG/ML VIAL, manufactured by Amgen Inc., is $185.3625 per ML (NDC 55513000204), effective Apr 15, 2026.
How has the price of ARANESP 25 MCG/ML VIAL changed over time?
Over the history we have for it, the NADAC for ARANESP 25 MCG/ML VIAL has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for ARANESP 25 MCG/ML VIAL?
Since Apr 23, 2025, the NADAC for ARANESP 25 MCG/ML VIAL has ranged from a low of $185.3625 (Apr 23, 2025) to a high of $185.3625 (Apr 15, 2026), with a median of $185.3625 per ML.
Are there cheaper alternatives to ARANESP 25 MCG/ML VIAL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ARANESP 25 MCG/ML VIAL, but none are currently priced below it.
Who manufactures ARANESP 25 MCG/ML VIAL?
ARANESP 25 MCG/ML VIAL (NDC 55513000204) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification